Pharmacy Podcast Network

PBMs make it a habit to use PSAOs as a scapegoat for a variety of issues in pharmacy - but what really is a PSAO?  Listen in as Monique Whitney, speaks with independent pharmacy owner and former APA CEO, Scott Pace, and EPIC VP of Network Development, Bretta Grinsteinner. It's a frank discussion about what PSAOs are, what they are not, and why dispelling the myths and misinformation is so important.

Get the inside scoop from a widely successful pharmacy owner and entrepreneur! In this episode CEO and Founder of Happier at Home, Debbie Marcello, and Todd Eury of the Pharmacy Podcast speak with Adam Robinson, owner of Save Rite Drugs. They discussed Adam’s journey through becoming a multiple unit pharmacy owner; his challenges, how he has grown as a leader, his strategies for growth and his future plans for increasing the quality of care in his community. Adam also discussed embracing the hub and spoke model and continued expansion. This is a jam packed episode that you do not want to miss!

The right technology can have a incredible impact to patient-care. CGM monitor technology to diabetics and the impact to primary care and pharmacy. TailorMed harnesses technology to improve the financial performance of healthcare providers and reduce the financial hardship for patients.

Your immunization program could be building your pharmacy business, one vaccine at a time. RMS was thrilled to welcome special guest, Ghada Abukuwaik, RPh to CLIMB in December 2022 to discuss how pharmacies can grow through vaccine programs, improve patient care, and drive profitability. This one-on-one with Ghada covers why vaccines are such an important part of pharmacy business, key pillars of immunization programs, challenges and how to overcome them, plus so much more. Don't miss this exclusive conversation with a pharmacy industry innovator!

Dr. Sue Ojageer is a award winning pharmacist with over 15 years of experience. She is a patient advocate and trusted source of information for those seeking genuine practitioner-patient relationships. She received her Doctorate of Pharmacy from St. John’s University and specializes in precision medicine, including pharmacogenomic and nutrigenomic testing for personalized medication therapy. Dr. Sue founded PharmaSue to revive the traditional patient-pharmacist relationship in today's fast-paced healthcare environment. Through her platform, she offers exceptional pharmaceutical care, precision medicine, and a holistic approach to health. As a mother of five children and active social media influencer, Dr. Sue educates, inspires, and informs her followers on her experiences as a pharmacist, mom, entrepreneur and influencer. She prioritizes personalized and individualized treatment plans, empowering her clients to take control of their health and fostering a sense of ownership and responsibility for their well-being. She recently published a childrens book, The Pharma Heroes. A captivating book which takes readers on an adventure as they use learn to use the power of precision medicine to solve a medical mystery. Her ultimate goal is to revolutionize the healthcare industry by enabling people to maximize their health potential and optimize overall well-being. With her compassionate approach to care and strong patient-pharmacist dynamic, Dr. Sue is leading the way towards a healthier future. https://www.pharmasue.com/   This episode is sponsored by FRAMEWORK LTC

Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom G7 User Guide. For product-related questions, please refer to the instructions for use. For complete safety information, go to dexcom.com/safety-information.   Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer. Smart devices are sold separately. For a list of compatible smart devices, visit: dexcom.com/compatibility. The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Dexcom G7 has no limitations for use in pregnancy. Amy Valent, MD is a paid spokesperson for Dexcom and is a guest on this episode of the podcast. About Hello Dexcom   Dexcom Provider website   Dexcom’s partners are working to integrate insulin pumps, insulin pens, and digital health apps with Dexcom G7. Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products.   A separate Follow app and internet connection are required to follow CGM users’ glucose readings and trends. CGM users should always confirm glucose readings on the Dexcom G7 app or receiver before making treatment decisions. Brief Safety Statement BRIEF SAFETY STATEMENT: Failure to use the Dexcom G7 Continuous Glucose Monitoring System (G7) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose0 or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G7 do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. Dexcom Clarity Safety Information The web-based Dexcom Clarity software is intended for use by both home users and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them. Caution: Federal (US) law restricts this device to sale by or on the order of a licensed healthcare professional. Dexcom, Dexcom Follow, Dexcom Clarity, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries. References Dexcom G7 User Guide Satish K. Garg, MD, et al. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes.Diabetes Technology & Therapeutics.Jun 2022.373 380.http://doi.org/10.1089/dia.2022.0011. Denice S Feig, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.  

We discuss new cloud-based software technology platforms empowering long term care pharmacies for the future and government policy's impact on pharmacists positioning in addiction medicine.   Visit Omnipod.com for more information about this episode's sponsor.

Olufunke Sokan, Pharm.D., advanced practice pharmacist at the University of Maryland School of Pharmacy and lead author of the study to discuss the study findings and how clinicians used tech to monitor prescription fill patterns and counsel patients accordingly. Patients with chronic heart disease and lung disease are more likely to fill their prescriptions when enrolled in a Mobile Integrated Healthcare and Community Paramedicine (MIH-CP) program after hospital discharge according to a new study by the University of Maryland just published this month.   Prescription first-fill rates increased by nearly 20% for patients with congestive heart failure (CHF) and 25% for patients with chronic obstructive pulmonary disease (COPD) in the first 30 days after enrollment. The six-month pilot also improved medication adherence by 8% to 14% in the 60 days after a pharmacist-led intervention. Because the improvements did not continue beyond 30-60 days, the study authors suggest that adding additional interventions could achieve an ongoing impact on medication adherence. the press release!

Ryan Oftebro, PharmD, FACA, CEO of independent Kelley-Ross Pharmacy Group, joins us for an open conversation about pharmacy benefit managers (PBM) fresh off his testimony on Capitol Hill. Oftebro spoke to the Senate Committee on Commerce, Science, and Transportation, during a hearing addressing how the “Pharmacy Benefit Manager Transparency Act” will bring transparency into PBM business practices and prohibit unfair or deceptive PBM conduct.

Biography Dr. Bratberg is well acquainted with the challenges community pharmacists and pharmacies face regarding opioid safety, overdose, harm reduction, and addiction pharmacotherapy. In 2012, Dr. Bratberg, along with a URI student pharmacist, co-developed an overdose education and naloxone training program for pharmacists in the first-in-nation statewide Collaborative Pharmacy Practice Agreement for naloxone.   He is an unpaid consultant for prescribetoprevent.org and prevent-protect.org, websites devoted to opioid overdose education and naloxone training for health professionals, community members, and health departments. In 2015, he was selected to serve as a member of the RI Governor’s Overdose Prevention and Intervention Task Force, to create and implement a plan that addresses prevention, treatment, overdose reversal, and recovery of citizens affected by opioid use disorders. He has been a consultant or co-investigator on federal grants from NIDA, CDC, AHRQ, NIGMS, RI EOHHS, and the URI Foundation. Dr. Bratberg is the 2016 NASPA National Cardinal Health Generation Rx Award winner. The Generation Rx Champions Award honors a pharmacist who has demonstrated outstanding commitment to raising awareness of the dangers of prescription drug misuse among the general public, as well as the pharmacy community. Finally, Dr. Bratberg is the guest editor of the first ever Special Issue on Opioid Safety and Naloxone of the Journal of the American Pharmacists Association (Mar/April 2017). Reference  https://www.statnews.com/2023/02/08/addiction-pregnancy-treatment-not-criminalization/